Literature DB >> 23604698

Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study.

Philippe Lesclous1, Sophie Grabar, Semaan Abi Najm, Jean-Pierre Carrel, Tommaso Lombardi, Jean-Louis Saffar, Jacky Samson.   

Abstract

OBJECTIVES: Actually, consensus management of osteonecrosis of the jaws (ONJ) related to nitrogen-containing bisphosphonates (NBPs) is mostly a conservative approach. It does not always control the symptoms and the progression of the disease. The aim of this study was to evaluate the clinical and radiological outcomes of three therapeutic management strategies of established ONJ.
MATERIALS AND METHODS: Three treatment strategies, i.e., conservative approach, minimal invasive surgery, and extensive surgery were evaluated in 39 ONJ patients treated with NBPs for malignant diseases or osteoporosis. The patients were closely monitored, and the outcome (extension, improvement, or healing) of mucosa and bone was clinically and radiographically evaluated on a long-term period (27.05 ± 2.96 months).
RESULTS: Primary pathology (osteoporosis or malignancies) and clinical severity of ONJ (mild, moderate, severe) were decisive factors. Osteoporotic patients showed more frequently complete mucosa or bone healing (p = 0.0128 and p = 0.00021, respectively) than malignant patients. Mucosa closure and bone improvement occurred more in mild ONJ patients than in severe ONJ (p = 0.0053 and p = 0.0319, respectively). Treatment strategy appeared to be a crucial factor for mucosa but not for bone healing. The rate of complete mucosa healing increased after an extensive surgical procedure (p = 0.0096).
CONCLUSIONS: A surgical management of patients with ONJ positively influenced the clinical outcome by enhancing mucosa healing. CLINICAL RELEVANCE: These results deserve further investigations involving a larger cohort. However, they strongly suggest that the guidelines of management of patients with ONJ related to NBPs have to be reconsidered.

Entities:  

Mesh:

Year:  2013        PMID: 23604698     DOI: 10.1007/s00784-013-0979-2

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  42 in total

1.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

2.  Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap.

Authors:  Juliana Lemound; Andrè Eckardt; Horst Kokemüller; Constantin von See; Pit Jacob Voss; Frank Tavassol; Martin Rücker; Majeed Rana; Nils-Claudius Gellrich
Journal:  Clin Oral Investig       Date:  2011-08-05       Impact factor: 3.573

Review 3.  Alveolar bone and the alveolar process: the socket that is never stable.

Authors:  J L Saffar; J J Lasfargues; M Cherruau
Journal:  Periodontol 2000       Date:  1997-02       Impact factor: 7.589

Review 4.  Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors:  Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal:  Ann N Y Acad Sci       Date:  2011-02       Impact factor: 5.691

5.  Surgical management of bisphosphonate induced osteonecrosis of the jaws.

Authors:  R A Williamson
Journal:  Int J Oral Maxillofac Surg       Date:  2009-12-16       Impact factor: 2.789

Review 6.  Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

Authors:  Ingo J Diel; Ignac Fogelman; Bilal Al-Nawas; Bodo Hoffmeister; Cesar Migliorati; Joseph Gligorov; Kalervo Väänänen; Liisa Pylkkänen; Martin Pecherstorfer; Matti S Aapro
Journal:  Crit Rev Oncol Hematol       Date:  2007-09-12       Impact factor: 6.312

7.  Inhibition of oral mucosal cell wound healing by bisphosphonates.

Authors:  Regina Landesberg; Matthew Cozin; Serge Cremers; Victoria Woo; Stavroula Kousteni; Satrajit Sinha; LeeAnn Garrett-Sinha; Srikala Raghavan
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

8.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.

Authors:  Mark A Scheper; Ashraf Badros; Risa Chaisuparat; Kevin J Cullen; Timothy F Meiller
Journal:  Br J Haematol       Date:  2008-11-20       Impact factor: 6.998

10.  Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid.

Authors:  Marco Mozzati; Germana Martinasso; Marina Maggiora; Matteo Scoletta; Marta Zambelli; Stefano Carossa; Manuela Oraldi; Giuliana Muzio; Rosa Angela Canuto
Journal:  Clin Oral Investig       Date:  2012-08-03       Impact factor: 3.573

View more
  5 in total

1.  Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.

Authors:  Pit Voss; Ute Ludwig; Philipp Poxleitner; Veronika Bergmaier; Nora El-Shafi; Dominik von Elverfeldt; Vincent Stadelmann; Jan-Bernd Hövener; Tabea Flügge
Journal:  Dentomaxillofac Radiol       Date:  2016-02-05       Impact factor: 2.419

Review 2.  Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches.

Authors:  Thomas Lombard; Virginie Neirinckx; Bernard Rogister; Yves Gilon; Sabine Wislet
Journal:  Stem Cells Int       Date:  2016-09-18       Impact factor: 5.443

Review 3.  The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ).

Authors:  Jorge A Cano-Durán; Juan-Francisco Peña-Cardelles; Daniel Ortega-Concepción; Víctor M Paredes-Rodríguez; Mariano García-Riart; Juan López-Quiles
Journal:  J Clin Exp Dent       Date:  2017-08-01

Review 4.  Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.

Authors:  Sung-Woon On; Seoung-Won Cho; Soo-Hwan Byun; Byoung-Eun Yang
Journal:  Antioxidants (Basel)       Date:  2021-04-27

Review 5.  Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.

Authors:  Lina He; Xiangyu Sun; Zhijie Liu; Yanfen Qiu; Yumei Niu
Journal:  Int J Oral Sci       Date:  2020-10-21       Impact factor: 6.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.